about
"Control" laboratory rodents are metabolically morbid: why it mattersLack of predictability at work and risk of acute myocardial infarction: an 18-year prospective study of industrial employeesNo Hypertensive Disorder of Pregnancy; No Preeclampsia-eclampsia; No Gestational Hypertension; No Hellp Syndrome. Vascular Disorder of Pregnancy Speaks for AllNon-Alcoholic Fatty Pancreatic Disease: A Review of LiteratureAir pollution effects on the gut microbiota: a link between exposure and inflammatory diseaseImplications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic targetAssociation of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.Dietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data.Sphingomyelin phosphodiesterase-1 (SMPD1) coding variants do not contribute to low levels of high-density lipoprotein cholesterol.Pregnancy: An Underutilized Window of Opportunity to Improve Long-term Maternal and Infant Health-An Appeal for Continuous Family Care and Interdisciplinary Communication.An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice.Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in men with hypertriglyceridemia.IL1B genetic variation and plasma C-reactive protein level among young adults: the CARDIA study.A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet.Nitrates and nitrites in the treatment of ischemic cardiac diseaseRole of metabolic syndrome components in human immunodeficiency virus-associated stroke.PPARs, Obesity, and InflammationMRI sagittal abdominal diameter is a stronger predictor of metabolic syndrome than visceral fat area or waist circumference in a high-risk vascular cohort.Left ventricular hypertrophy, geometric patterns and clinical correlates among treated hypertensive Nigerians.The gut microbiota, environment and diseases of modern society.Metabolic syndrome: comparison of occurrence using three definitions in hypertensive patients.Stem cells in the diabetic infarcted heartHuang-lian-jie-du-tang protects rats from cardiac damages induced by metabolic disorder by improving inflammation-mediated insulin resistance.Body mass and white matter integrity: the influence of vascular and inflammatory markers.Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease.Natural occurrence of aflatoxin residues in fresh and sun-dried meat in Nigeria.Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetesCorrelation of Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) and Retinoid X Receptor-alpha (RXR-alpha) expression with clinical risk factors in patients with advanced carotid atherosclerosis.Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis.Raisins and additional walking have distinct effects on plasma lipids and inflammatory cytokines.Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.Annexin A6 is highly abundant in monocytes of obese and type 2 diabetic individuals and is downregulated by adiponectin in vitroSilymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor.Chronic discrimination predicts higher circulating levels of E-selectin in a national sample: the MIDUS study.The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention.Hyperlipidemia: a new therapeutic target for diabetic neuropathy.Association of retinol-binding protein 4 with metabolic syndrome in first-degree relatives of type 2 diabetic patients.PPARs and their effects on the cardiovascular system.Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
P2860
Q24599731-E5685E10-7951-46BE-91C6-A9002AEA51F1Q24657803-FA36A2EB-E2EF-4AA2-9CF0-8C045DC41D85Q26746049-B1C62480-4C68-45BF-A414-A56194094C4BQ28354330-E50F9161-002F-491A-8CCF-3897534C95D3Q28657873-70D5E029-DB85-44CE-B6F7-3B07F0A895BAQ30370672-7A004A80-C951-4860-A45C-352571876E97Q30384917-6C5A4BF0-B694-4E15-BD47-623CAAC5AE77Q31157315-7886CA52-E716-48E4-A824-FAA75E50CE7DQ33310999-C2C1EEB5-A163-4C25-8536-1D2A8E02BC14Q33559194-48C7DFCE-F9E1-4E8A-A789-0B6B4C943CC9Q33609414-387E7B55-F6CB-4CC0-848A-BEF9287E9C75Q33609756-4FC898F9-D5D3-42DE-8038-88DD4FC81890Q33762567-2B1B2AED-A4FD-4CC6-8B96-87FDE4E67C0FQ33858409-DB1836F5-F4BA-4107-94A7-20F07F0F74F8Q33910541-EDE61435-F942-4EF4-85B2-26BC056231F1Q33938800-ACDA7EED-A281-4CDC-B66A-EF21E6713CC8Q34003196-A280F933-12DA-4E6F-B099-E6A5A035C3E1Q34068779-2005808F-F93C-4E5F-B00E-7385003B008AQ34321132-A2B6BF17-F218-469F-8BA5-EDF14D412FAFQ34348985-5927DD5E-57C3-43C3-B27A-BDB3083F43DEQ34723371-3F86DAC4-5BAD-41E4-8129-BF3BA096D7E7Q34773408-99738CB6-FD99-4B47-9CC8-8FB835EC83F9Q34807603-AED02D19-E2E5-4450-8EA6-E4728A5C6230Q35023378-F2954BD2-34D3-49F2-9EDA-0EA70CE9234EQ35085125-FD8D0F49-7D7E-4034-BBA2-22EC538A2E16Q35211837-A3AA9CEE-EFC5-40AC-AA0A-54E23127B72FQ36513259-2D26D289-7CC2-4513-AD3D-F4DCB61E8543Q36516569-BF698370-2226-4EF0-B388-CDC993F4B4EBQ36576768-C22962C7-3D17-44A8-9CFE-99195E481213Q36579236-836DD977-87E7-45AC-B3A3-3B5F18B5F9D6Q37163795-500DD37B-A103-4B6F-85D9-DE49B0C82FADQ37290031-E83D302C-71FD-46F5-AA6C-CC681482CDEFQ37290054-8ACE0D20-20C5-4265-BCB0-85F96118D83AQ37351334-6AB84BC3-A064-48B4-8B28-3F877E9FCCC6Q37580976-A0F4B6CD-100D-41FD-B9FD-AD6EE050555FQ37659233-837A5DA3-6041-47AD-8E6D-F564F0BB54A7Q37735276-A47CEFA1-29D0-4FD5-BB82-CE6E4EEAAA2DQ37896654-F48D4A81-8357-4E04-A38F-AFFEDD46FABEQ38008136-D7B0BDBE-D426-4DFE-B487-FC1FE423F5DFQ38294486-1A7293A6-A8AE-4B5E-8EEE-B4238A20F01C
P2860
description
im Januar 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2006
@uk
name
The metabolic syndrome and cardiovascular disease
@en
The metabolic syndrome and cardiovascular disease
@nl
type
label
The metabolic syndrome and cardiovascular disease
@en
The metabolic syndrome and cardiovascular disease
@nl
prefLabel
The metabolic syndrome and cardiovascular disease
@en
The metabolic syndrome and cardiovascular disease
@nl
P2860
P1433
P1476
The metabolic syndrome and cardiovascular disease
@en
P2093
Enzo Bonora
P2860
P356
10.1080/07853890500401234
P407
P50
P577
2006-01-01T00:00:00Z